Walleye Capital’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Walleye Capital’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$127K	Hold	169,502	–	–	﹤0.01%	3569
2025 Q4	$120K	Sell	169,502 -300	-0.2%	-$250	﹤0.01%	3797
2025 Q3	$127K	Hold	169,802	–	–	﹤0.01%	3585
2025 Q2	$149K	Buy	169,802 +64	+0%	+$49	﹤0.01%	3566
2025 Q1	$127K	Buy	169,738 +54,122	+47%	+$41.1K	﹤0.01%	3518
2024 Q4	$102K	Buy	+115,616	New	+$75.6K	﹤0.01%	4134

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Walleye Capital's OACCW Position: Q1 2026 in Review

Walleye Capital held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 169,502 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Walleye Capital first reported a position in OACCW in Q4 2024 and has held it in 6 quarters since. The position peaked at $149K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

Walleye Capital held 169,502 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $127K as of Q1 2026.
Walleye Capital left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3569 holding.
Walleye Capital first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 6 quarters since.
Walleye Capital's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $149K in Q2 2025.
26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.